AbbVie (ABBV) Inventory Average (2013 - 2026)

AbbVie (ABBV) has reported Inventory Average for 14 consecutive years, with $5.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 7.27% year-over-year to $5.1 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 7.27% increase from a year earlier, with the FY2025 full-year figure at $4.6 billion, up 10.29% from the prior year.
• Inventory Average was $5.1 billion for Q2 2026 at AbbVie, up from $5.0 billion in the prior quarter.
• Over five years, Inventory Average peaked at $5.1 billion in Q2 2026 and troughed at $3.3 billion in Q3 2022.
• A 5-year average of $4.2 billion and a median of $4.2 billion in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average advanced 0.44% in 2022 and increased 22.35% in 2023, its largest moves.
• Over 5 years, Inventory Average stood at $3.4 billion in 2022, then increased by 19.69% to $4.0 billion in 2023, then increased by 6.82% to $4.3 billion in 2024, then gained by 14.58% to $4.9 billion in 2025, then advanced by 2.9% to $5.1 billion in 2026.
• The last three Inventory Average figures came in at $5.1 billion (Q2 2026), $5.0 billion (Q1 2026), and $4.9 billion (Q4 2025), per Business Quant data.